Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: All trans-retinoic acid|DRUG: 13-Cis Retinoic Acid plus Tocopherol|DRUG: Mifepristone|DRUG: Cannabidiol|DRUG: 9 cis retinoic acid|DRUG: Tamoxifen|DRUG: Standard therapy
Sponsor: Mahmoud Ramadan mohamed Elkazzaz
Collaborators: Ministry of Health, Saudi Arabia